Live News Categoriesequity

Daewoong Pharmaceutical Co., Ltd (069620.KS) News

Track canonical SquawkNews coverage tagged to 069620.KS, Daewoong Pharmaceutical Co., Ltd. This hub brings together deduplicated headlines about kse, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 069620.KS Asset equity Sector Markets 90 days 1 Last 106,200 Updated Sep 24, 2026, 07:01 AM UTC Open live news feed

L Daewoong Pharma reports 104 patients enrolled in Phase 2 IPF trial of Bersiporocin Daewoong Pharma presented baseline data for 104 patients in a global Phase 2 trial of IPF candidate bersiporocin at ERS 2026. The study is designed to test the drug in patients already on standard antifibrotic therapy, a NEWS | Sep 24, 2026, 07:01 AM UTC